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Premature activation of digestive enzymes within the pancreas which leads to autodigestion of the gland is an early step in the pathogenesis of
pancreatitis. Pancreatic injury is followed by other manifestations of inflammation including plasma extravasation, edema, and neutrophil
infiltration which constitute the features of pancreatitis. Recent studies indicate that neural innervation of the pancreas may play an important role
in the initiation and maintenance of the inflammatory response to injury. The pancreas is innervated by vagal, sympathetic and parasympathetic
neurons, as well as sensory neurons. Activation of pancreatic primary sensory neurons causes the release of inflammatory neuropeptides both in
the spinal cord to signal pain and in the pancreas itself where they produce plasma extravasation and neutrophil infiltration. Recent studies indicate
that primary sensory neurons of the pancreas express transient receptor potential V1 (TRPV1) channels whose activation induces pancreatic
inflammation. Moreover, blockade of these TRP channels significantly ameliorates experimental pancreatitis. This review describes our current
understanding of the role of TRPV1 channels in pancreatitis and illustrates how this mechanism might be used to direct future treatments of
pancreatic diseases.
© 2007 Elsevier B.V. All rights reserved.Keywords: Acute pancreatitis; Chronic pancreatitis; Experimental pancreatitis; Neurogenic inflammation; Substance P; Vanilloid receptor; VR1; Capsaicin receptor1. Introduction
The exocrine pancreas synthesizes, stores, and secretes
digestive enzymes essential for normal digestion. Pancreatic
injury often initiates conversion of the proenzyme trypsinogen
to its active form trypsin. When typsin exceeds the capacity of
endogenous trypsin inhibitors, activation of other zymogens
occurs within the pancreas producing a proteolytic cascade that
ultimately causes autodigestion of the gland [1]. Pancreatitis
develops when this destructive process is accompanied by
inflammatory features including cytokine release, vasodilation,
edema, and neutrophil infiltration [2].
The pancreas is innervated by the vagus nerve containing
cholinergic neurons that regulate exocrine section as well as
parasympathetic and sympathetic neurons that modulate both
endocrine and exocrine function [3]. The vagus nerve and
splanchnic nervous system contain both stimulatory and⁎ Tel.: +1 919 681 6380; fax: +1 919 668 0412.
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of pancreatic enzymes, fluid, and bicarbonate necessary for
digestion of a meal. In addition, the pancreas is supplied with
sensory neurons that contain vasoactive and inflammatory
neuropeptides such as bradykinin, calcitonin gene-related peptide
(CGRP) and substance P [4–6]. These nerves are responsible for
signaling painful stimuli originating in the pancreas. It has long
been recognized that certain neural influences may induce
inflammation [7]. This process known as neurogenic inflamma-
tion is characterized by vasodilation, edema, and neutrophil
infiltration and can be reproduced by specific neuropeptides such
as bradykinin, CGRP and substance P [8].
These actions raise the possibility that sensory neurotrans-
mitters may contribute to the inflammatory response following
pancreatic injury. Only recently has the role of sensory nerves in
the pancreas been extensively examined.
2. Features of acute pancreatitis
Acute pancreatitis is associated with intra-acinar cell
activation of digestive enzymes [9]. Under normal conditions,
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activated, but further proteolytic activation of other enzymes
does not occur because trypsin is inactivated by either
endogenous trypsin inhibitors or enzymatic autodigestion of
trypsin itself. However, when the amount of activated trypsin is
high, as occurs with certain forms of pancreatic injury, and
exceeds the trypsin inhibitory capacity of the pancreas,
uncontrolled proteolytic activation of pancreatic proenzymes
transpires leading to acinar cell autolysis and necrosis [10,11].
Secretion of digestive enzymes is reduced and fusion of
zymogen granules with lysosomes can be observed [12].
Zymogen-lysosomal granule fusion may contribute further to
enzyme activation [13]. As is true in many examples of tissue
injury, pancreatic damage and initiation of the autodigestive
process is followed by release of cytokines and other
inflammatory mediators that ultimately cause acute inflamma-
tion [14]. Pancreatic inflammation may cause more extensive
pancreatic injury before resolution occurs. Severe pancreatitis is
associated with extensive tissue necrosis.
Experimentally, acute pancreatitis can be reproducibly
induced by administering supraphysiological amounts of the
secretagogue, caerulein; feeding a diet deficient in choline and
supplemented with ethionine; ligating the bile-pancreatic duct;
or injecting high amounts of arginine [1]. Although the severity
of pancreatitis and tissue necrosis varies among these different
models, the fundamental features of zymogen activation,
reduction in enzyme secretion, and plasma extravasation,
edema, and neutrophil infiltration within the pancreas are
common to all of these models.
3. Neurogenic inflammation
Neurogenic inflammation occurs following activation of
sensory neurons and release of bioactive substances that
produce vasodilation, edema, and other manifestations of
local inflammation. Primary sensory neurons innervate the
entire body (except the brain) and are responsible for the
detection of pain and transmission of painful stimuli to the
central nervous system. The cell bodies of primary sensory
neurons reside in dorsal root ganglia and send axonal
projections centrally to the spinal cord and peripherally to
innervate specific organs including the pancreas. Neurotrans-
mitters are released from sensory neurons following activation
by dorsal root reflexes, axonal reflexes, or local depolarization
[8]. The role of sensory neurons is to relay information from the
periphery to the central nervous system. When a sensory nerve
is stimulated an orthodromic signal is generated and neuro-
transmitters are released in the spinal cord which, when relayed
to the brain, signal pain. However, when neuronal depolariza-
tion occurs, an antidromic signal is also generated and
neurotransmitters are simultaneously released at the peripheral
end of the neuron. Therefore, stimulation of primary sensory
neurons has the ability to activate neurons in the spinal cord to
signal pain as well as release neurotransmitters in the periphery
that exert other bioactive effects.
Primary sensory neurons contain a number of bioactive
transmitters some of which cause local inflammation. Twosubpopulations of unmyelinated neurons, known as C and Aδ
fibers, are particularly relevant since these contain the
tachykinins neurokinin A, neurokinin B, and substance P as
well as calcitonin gene-related peptide (CGRP), glutamate, and
adenosine, all of which have proinflammatory actions. Local
substance P release has been measured using a novel
immunological technique to detect substance P-stimulated
internalization of the substance P receptor [known as neurokinin
1 (NK1) receptor] [15]. These studies have demonstrated that
substance P is released in the spinal cord and in the periphery
following sensory nerve stimulation [16,17].
Substance P and CGRP appear to be responsible for many of
the features of neurogenic inflammation. Not only are both
neuropeptides released by C and Aδ fibers but they have the
abilities to interact with endothelial cells, arterioles, mast cells
and other immune cells to induce vasodilation, edema and
inflammatory cell infiltration. The manifestations of neurogenic
inflammation can be mimicked by local administration of
substance P and CGRP and these effects can be blocked by
administration of immunoneutralizing peptide antibodies or
substance P or CGRP receptor antagonists. Moreover, inflam-
matory responses to injury or substance P are substantially
reduced in mice with genetic deletion of substance P receptors
[18].
The effects of substance P and CGRP are transient; however,
following severe injury, the manifestations of neurogenic
inflammation are more profound. Under pathological condi-
tions, neutrophil infiltration and mast cell degranulation amplify
the inflammatory response by releasing proinflammatory
molecules that cause neutrophil adhesion, migration, and
release of reactive oxygen species [19–21].
Sensory neurons respond to physical and chemical stimuli. C
and Aδ fibers are particularly noteworthy because they are
sensitive to capsaicin, the active ingredient in hot peppers.
Capsaicin, acting through C and Aδ neurons, induces feelings
of warmth and in high concentrations causes inflammation. The
actions of capsaicin on the bronchial tree, skin, joints, and
gastrointestinal tract have been well documented [22]. Through
its effects on sensory neurons, injection of capsaicin causes
hypersensitivity, redness due to vasodilation, and edema due to
plasma extravasation. However, these phenomena can be
prevented by repeated administration of capsaicin which
depletes neurotransmitters from nerve terminals. Interestingly,
administration of very high amounts of capsaicin, particularly to
neonatal animals, which are exquisitely sensitive to the
compound, destroys C and Aδ neurons and renders animals
insensitive to capsaicin-induced inflammation [23].
A major advance was the discovery and molecular cloning of
the capsaicin receptor [24] which is expressed on C and Aδ
fibers. Based on the structure of its ligand, the capsaicin
receptor was originally named the vanilloid receptor 1 (VR1)
but it was soon recognized that it was a cation channel and has
since been renamed transient receptor potential vanilloid type 1
(TRPV1). TRPV1 is a non-selective cation channel and when
activated, permits the flow of cations such as sodium and
calcium from the outside to the inside of the cell. Cation influx,
of which sodium is likely to be the most important, causes the
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of neurotransmitters, such as substance P, from nerve terminals.
Capsaicin, by activating TRPV1, is highly specific for C and Aδ
fibers and causes neuronal release of substance P and CGRP.
TRPV1 is not only activated by capsaicin, but also by heat
and protons [25]. Increasing the temperature of tissues reduces
the threshold for activation of TRPV1 and leads to substance P
and CGRP release in both the spinal cord and periphery. Mice in
which the TRPV1 gene was deleted are less sensitive to the
application of painful heat [26]. Thus, TRPV1 is one of the
mechanisms that sense local increase in temperature. In
addition, acidification of the extracellular environment also
activates TRPV1 (Table 1). The convergence of heat, acid and
capsaicin on TRPV1 explains, in part, why pepper (i.e.,
capsaicin) feels hot. In low concentrations, capsaicin induces
feelings of warmth, but in high concentrations, through the
release of proinflammatory neuropeptides such as substance P,
is highly inflammatory and causes plasma extravasation.
Moderate acidity (pH≤6.4) lowers the temperature threshold
for activation of TRPV1 such that activation can occur at 37 °C.
Thus, the burning sensations associated with application of acid
or local acidification of tissue appears to occur through
activation of TRPV1 neurons [27]. Importantly, it appears that
one of the major effects of protons on sensory nerves is to
potentiate the responses of other activators of TRPV1 [28].
Under physiological conditions, capsaicin-sensitive sensory
nerves are probably responsible for signaling local increases in
temperature which are interpreted as painful heat. Release of
inflammatory neuropeptides may produce local edema and
other sequelae that lead to the process of normal repair
following tissue injury. Under pathophysiological conditions,
more extensive involvement of sensory neurons produces
excessive neuropeptide release that may exacerbate inflamma-
tion. This may explain why substance P pathways have been
implicated in diseases such as arthritis, asthma, and inflamma-
tory bowel disease [28].
Capsaicin is a plant molecule that is not produced by
mammalian species. Therefore, following the discovery of
TRPV1, considerable investigation has been devoted to
identifying endogenous activators of the “capsaicin receptor”
TRPV1 and the mechanisms that signal heat hyperalgesia [29].
It has since been recognized that the temperature threshold of
TRPV1 is lowered by proinflammatory mediators such as
bradykinin, ATP and other signaling molecules that activate
protein kinase C (PKC) [30–32]. TRPV1 is also sensitized by
phosphatidylinositol-4,5-bisphosphate (PIP2) hydrolysis afterTable 1
Putative mechanisms regulating TRPV1 [84]
Physical activators Chemical activators Temperature range Sensory nerve
Thermal Protons >42 °C C fibers




It should be noted that the temperature threshold for activation is lowered in the
presence of other channel activators.phospholipase C activation [33]. Interestingly, protease-
activated receptor 2 (PAR-2), which may have a role in
pancreatitis, has been shown to potentiate TRPV1 activation
through a PKC-dependent mechanism [34]. By lowering the
temperature threshold, TRPV1 can be activated at temperatures
lower than 42 °C, thus increasing the sensitivity of the ion
channel to other endogenous mediators. Other proinflamma-
tory mediators such as prostaglandins which activate protein
kinase A (PKA) phosphorylate TRPV1 and cause a reduction
in desensitization of the channel [35]. Nerve growth factor
(NGF) has been shown to regulate TRPV1 expression through
two mechanisms. First, NGF sensitizes TRPV1-bearing
neurons by increasing the number of ion channels in the cell
membrane [36]. NGF activates PI3 kinase which, through Src
phosphorylation, induces the rapid movement of TRPV1
channels to the plasma membrane. A second, long-term effect
is NGF's ability to upregulate de novo expression of TRPV1
through activation of the Ras-MAPK pathway [37,38].
Capsaicin is similar in structure to some endogenous lipid
molecules including members of the arachidonic acid family.
This similarity raised the possibility that related molecules may
be able to interact with TRPV1. Subsequently, the lipid
mediator anandamide and the proinflammatory leukotriene B4
(LTB4) have recently been shown to directly activate TRPV1
and play essential roles in the inflammatory response following
an injurious insult [39,40]. These findings indicate that
endogenous TRPV1 signaling molecules exist in several
forms. Since molecules like anandamide and LTB4 are
generated during tissue injury, they are primed to activate
primary sensory neurons through their actions on TRPV1 which
leads to the release of other inflammatory mediators such as
substance P.
Trypsin has been shown to activate primary sensory neurons
[41]. This observation is particularly pertinent in pancreatitis,
since activation of trypsinogen to trypsin is a key step in the
initiation of the disease. Primary sensory neurons possess
proteinase-activated receptors (PARs) which are a family of G
protein-coupled receptors that are activated by proteases such as
trypsin or thrombin [42]. The unique feature of these receptors
is that they are activated when proteases cleave the amino
terminus of the extracellular region, exposing a new amino
sequence that functions as a tethered ligand. This new amino
terminus binds to and activates the PAR. Four PARs have been
identified (PARs 1–4). PARs 1, 3, and 4 are activated by
thrombin but PAR-2 is unique in that it is activated by trypsin
and tryptase. PAR-2 is expressed on neutrophils, endothelial,
epithelial, and mast cells and dorsal root ganglion neurons [43].
Activation of PAR-2 on vascular endothelial cells causes
vasodilation and in neurons PAR-2s are linked to sensory
neurotransmission. It was recently demonstrated in sensory
neurons that PAR-2 sensitizes TRPV1 by activating PKCε and
PKA to cause thermal hyperalgesia [44]. This mechanism may
also contribute to inflammatory pain, where multiple proteases
are generated that could activate PAR-2.
It is now apparent that proinflammatory mediators may
regulate TRPV1 directly or indirectly through other receptors
on sensory nerves. For example, capsaicin, protons, and heat
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which is structurally similar to capsaicin, also have direct effects
on TRPV1. In contrast, bradykinin binds to the B2 receptor,
which resides on primary sensory neurons and, through PKC,
stimulates primary sensory neurons and modulates TRPV1
activity [45]. The PAR-2 receptor is activated by extracellular
proteases and stimulates sensory neurons independently of
TRPV1. Leukotriene B4 is interesting because it can directly
activate TRPV1 or, by binding to its own LTB4 receptor,
activate intraneuronal signaling pathways that could indirectly
modulate TRPV1.
There are a number of compelling findings to indicate that
neural influences contribute to the pathogenesis of pancreatitis
[46]. First, in other systems, release of neuropeptides such as
substance P and CGRP induce pain and cause inflammation.
Second, antagonism of sensory neuropeptides (e.g., substance P
and CGRP) ameliorates inflammation. Third, agents that
activate TRPV1-bearing sensory neurons stimulate neuropep-
tide release and induce inflammation. Fourth, sensory neurons
containing potentially inflammatory mediators such as sub-
stance P are present in the pancreas.
4. Neuropeptides and substance P in pancreatitis
Several studies indicate that neurogenic inflammation may
be important in the development of acute pancreatitis.
Substance P is released from sensory nerves and binds to the
neurokinin 1 (NK1) receptor on endothelial and epithelial cells.
In the pancreas, acinar cells express NK1 receptors and
substance P-containing neurons are abundant. Substance P-
induced plasma extravasation in the pancreas is blocked by
NK1 receptor antagonists [47]. It was recently demonstrated
that pancreatic levels of substance P are elevated and NK1
receptor expression is increased in a model of caerulein-induced
acute pancreatitis [48]. Importantly, hyperamylasemia, hyperli-
pasemia, neutrophil sequestration in the pancreas, and pancrea-
tic acinar cell necrosis as well as pancreatitis-associated lung
injury were significantly reduced in NK1R knockout mice when
compared with wild-type animals [48]. These findings indicate
that substance P acting through NK1 receptors is proinflamma-
tory and is responsible, at least in part, for the severity of acute
pancreatitis. Similar protective effects were observed with
hemorrhagic pancreatitis induced by feeding mice a diet
deficient in choline, supplemented with ethionine (CDE diet)
in NK1 receptor knockout mice [49]. The precise roles of
substance P and its receptor were further investigated using
selective NK1 receptor agonists and antagonists [50]. In rats,
both substance P and NK1 receptor agonists and caerulein
administration stimulated pancreatic plasma extravasation and
this effect was blocked by an NK1 receptor antagonist. In
contrast to wild type mice, administration of exogenous
substance P did not induce pancreatic edema in NK1 receptor
knockout mice [50]. These findings indicate that substance P
and its receptor are essential for development of inflammatory
edema in acute pancreatitis.
The actions of substance P are terminated at the cell surface
of the effector cell by the cell surface enzyme neutralendopeptidase, which degrades substance P. In a lethal model
of hemorrhagic pancreatitis induced by the CDE diet, genetic
deletion of the NK1 receptor prevented diet-induced mortality
from pancreatitis and reduced acinar cell necrosis [51].
Conversely, genetic deletion of neutral endopeptidase signifi-
cantly worsened survival and exacerbated the severity of diet-
induced pancreatitis and associated lung injury. These findings
further support the important role of substance P in necrotizing
pancreatitis. It is interesting to speculate that defects in neutral
endopeptidase may play a role in clinical pancreatitis.
5. TRPV1 in pancreatitis
Experimental models have been extremely useful for
defining the organ-specific and cellular pathological processes
that occur during the development and evolution of pancreatitis.
Considerable data indicate that intra-pancreatic activation of
digestive enzymes are a necessary and early event and may
result from direct pancreatic injury [9,52]. The severity of
pancreatitis that follows is related to a number of interacting
factors that either exacerbate injury (e.g., generation of
proinflammatory mediators, ischemia, oxygen-derived free
radical generation, etc.), or protect the pancreas (e.g.,
endogenous trypsin inhibitors, mesotrypsin, etc.) that impact
the mode of cell death which itself may be deleterious. Among
the proinflammatory mediators that may contribute to pancrea-
titis severity, substance P has received particular attention. In
the gastrointestinal tract and pancreas, substance P has been
shown to stimulate plasma extravasation from postcapillary
venules [47]. Moreover, blocking substance P's actions with
specific NK1 receptor antagonists, or genetic deletion of the
NK1 receptor, reduced pancreatic edema and neutrophil
infiltration [47,48]. Innervation of the pancreas with sensory
neurons that contain proinflammatory transmitters such as
substance P and CGRP and localization of TRPV1 on these
neurons raise the possibility that sensory nerve activation in the
pancreas is instrumental in a neurogenic process that contributes
to the pathogenesis of pancreatitis.
If neurogenic components contributed significantly to the
severity of pancreatitis, it seemed reasonable that blocking
sensory nerves should reduce pancreatic inflammation. Capsa-
zepine is a synthetic competitive antagonist of capsaicin and
serves as a TRPV1 inhibitor. It has been studied in vitro and
blocks TRPV1 activation by capsaicin, heat and protons
[25,27]. It was recently demonstrated in vivo that capsazepine
significantly reduced inflammation and pancreatic injury in a
model of caerulein-induced acute pancreatitis [53].
One of the ways in which substance P activity is terminated
is through enzymatic degradation by the cell-surface metallo-
protease, neutral endopeptidase. This is particularly relevant in
pancreatitis since it has been shown that genetic deletion of
neutral endopeptidase exacerbates experimental pancreatitis
and its associated lung injury [54]. Although neutral endopep-
tidase clearly plays an important role in terminating substance
P-induced plasma extravasation, its effects on pulmonary
inflammation appear to be mediated through effects on elastase
which is injurious to the lung [55].
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subset of primary sensory neurons and is released following
nerve stimulation and depolarization. Using retrograde tracing
and immunohistochemistry it was shown that the pancreas is
innervated by substance P-containing nerve fibers that originate
from dorsal root ganglion cells [56] indicating that substance P
neurons are of extrinsic origin consistent with primary sensory
neurons. In addition, TRPV1 has been detected in nerve fibers
close in proximity to pancreatic acini [57]. The functional role
of these neurons was investigated in rats in which primary
sensory neurons expressing the capsaicin receptor (TRPV1)
were ablated during neonatal life by administration of
neurotoxic doses of capsaicin [58]. Systemic sensory denerva-
tion was documented by loss of eye-wipe responses to local
application of capsaicin. Importantly, when subjected to either
of two types of experimental pancreatitis (caerulein-induced
pancreatitis or pancreatitis produced by ligation of the common
bile-pancreatic duct), capsaicinized animals incurred much less
pancreatitis compared to non-capsaicinized animals. These
findings demonstrated that primary sensory neurons play a
significant role in the inflammatory cascade leading to
pancreatitis. Moreover, since only capsaicin-sensitive neurons
(which are those expressing TRPV1) are destroyed by
capsaicin administration, this study demonstrated that it is
TRPV1-bearing neurons that mediate neurogenic inflammation
in the pancreas.
There is now substantial experimental and even clinical
evidence that substance P release with subsequent activation of
the NK1 receptor plays a key role in the initiation of neurogenic
inflammation and parenchymal injury. Like other G protein-
coupled receptors, the NK1 receptor that normally resides on
the plasma membrane is internalized into the cell following
ligand binding. Both in vitro and in vivo studies have shown
that after substance P binding, the NK1 receptor undergoes
rapid internalization and is then recycled to the plasma
membrane after degradation of bound substance P. This process
of receptor endocytosis has been used as a measure of ligand
activity at the cell surface. Using an antiserum specific for the
carboxyl terminus of the NK1 receptor, it has been possible to
measure local substance P activity by quantifying NK1 receptor
immunoreactive endosomes [15,16,59]. This technique has the
advantage of indicating substance P at the cellular level since it
is a measure of substance P-stimulated receptor activation, not
just substance P content in tissue. It was shown that
experimental pancreatitis produced by repeated caerulein
injection in mice caused substance P release within the pancreas
and induced biochemical and histological evidence of acute
pancreatitis [53,60]. Moreover, pharmacological blockade of
TRPV1 with capsazepine reduced NK1 receptor endocytosis
(indicating reduced substance P release) and reduced the
severity of caerulein-induced pancreatitis. These findings
suggest that TRPV1 plays a central role in the evolution from
pancreatic injury to the full manifestations of pancreatitis. Thus,
it appears that supraphysiological doses of caerulein generate a
signal that activates TRPV1 on primary sensory neurons
resulting in substance P release. Substance P in turn propagates
the inflammatory cascade that, in the pancreas, is manifest asacute pancreatitis. Inhibition of TRPV1 diminishes substance P
release and reduces the severity of pancreatitis.
Serum amylase is commonly used as a marker of
pancreatitis. In several studies in which pancreatitis was
reduced through TRPV1 blockade, serum amylase levels were
elevated following the induction of pancreatic injury. Interest-
ingly, however, even though pancreatitis severity was reduced
by TRPV1 blockade or elimination of primary sensory neurons,
serum amylase levels were not significantly lower [53,58].
These findings suggest that amylase release is an early event in
the course of pancreatitis and is independent of primary sensory
neurons. Thus, serum amylase is a marker of pancreatic injury
but is not synonymous with pancreatitis.
The mechanisms underlying TRPV1 activation in pancrea-
titis are unknown. It has been well established that TRPV1 on
primary sensory neurons is directly activated by heat and
protons. Acidic conditions, in which the pH is≤6.4, are capable
of lowering the temperature threshold for TRPV1 at 37 °C. It is
interesting to note that pancreatic vacuole and lysosomal
compartments have high proton contents that are increased
under conditions of experimental pancreatitis [61,62]. It is
conceivable that these acidic compartments when damaged
following pancreatic injury help lower the tissue pH sufficiently
to activate TRPV1 at physiologic temperatures. In addition to
the possible proton contributions from lysosomes and pancrea-
tic vacuoles, it is known that high proton concentrations occur
locally in several injurious processes such as tissue ischemia,
infection, and inflammation [63–65]. Thus, the inflammation
that accompanies pancreatitis may be a source of protons that
can lower the temperature threshold for TRPV1 activation. It is
also possible that in addition to increasing proton concentra-
tions, pancreatic injury generates a molecule that activates
TRPV1. One possibility is the endocannabinoid anandamide
which is thought to play a role in initiating neurogenic
inflammation [66]. It has been shown that anandamide, which
was previously known to activate the cannabinoid CB1
receptor, regulates inflammatory neuropeptide release from
capsaicin-sensitive primary sensory neurons through TRPV1
[67]. In addition, endogenous leukotriene B4 can also activate
primary sensory nerves either through the LTB4 receptor or by
direct interaction with TRPV1 [28,39]. Many of the substances
that activate TRPV1 or sensitize the ion channel to other agents
are generated early in the development of pancreatitis; therefore,
there are multiple complementary pathways in which TRPV1
can be activated during the course of the disease.
It is well established that substance P targets NK1 receptors
on postcapillary venules and causes intercellular gaps to form
and it is this cellular site of action that is responsible for the
plasma extravasation and edema that occurs following sub-
stance P administration [50]. However, the contributions of the
NK1 receptor on acinar cells to pancreatic inflammation are less
well understood. Although NK1 receptor endocytosis in acinar
cells provides a very useful model for quantifying substance P
action within the pancreas, the physiological significance of
substance P stimulation of pancreatic acinar cells in pancreatitis
is unclear. In vitro studies have shown that substance P
exposure stimulates amylase release from pancreatic acinar
Fig. 1. A schematic diagram of the proposed role of TRPV1 in a model of
caerulein-induced pancreatitis. Hyperstimulation of the pancreas with caerulein
causes intra-pancreatic activation and release of digestive enzymes. Subsequent
tissue acidification (↑H+) or release of an endogenous TRPV1 agonist (↑?)
stimulates TRPV1 on primary sensory neurons. TRPV1 activation causes
neuronal depolarization and the release of substance P in both the spinal cord
and pancreas. Substance P in the pancreas causes tissue edema, neutrophil
infiltration and necrosis. Antagonism of TRPV1 with capsazepine does not
prevent pancreatic enzyme release but blocks TRPV1 and limits pancreatic
inflammation. (Modified from [53] with permission).
874 R.A. Liddle / Biochimica et Biophysica Acta 1772 (2007) 869–878cells. Whether the effects of substance P on acinar cells during
the evolution of pancreatitis are important for the progression of
pancreatitis has yet to be determined.
6. TRPV1 and pancreatic pain
It is well documented that TRPV1 is important in a variety of
pain models. Thus, in addition to its contributions to pancreatic
inflammation, it is likely that TRPV1 plays a role in the pain
response in pancreatitis [25,68]. Activation of TRPV1 on
neurons causes the release of both substance P and CGRP in the
dorsal horn of the spinal cord which is critical for transmitting
pain signals from the periphery to the central nervous system. A
number of subsequent studies have illustrated the role of
TRPV1 in mediating the effects of peripheral signals into pain
perceptions. Shortly after the cloning of TRPV1 it was shown
that genetic deletion of TRPV1 in mice impaired thermal
hypersensitivity associated with tissue inflammation [28].
Intrathecal injection of antagonists to the NK1 or CGRP
receptor (calcitonin-like receptor, CLR) has been shown to
inhibit the frequency of abdominal contractions in response to
colorectal distention which is a measure of allodynia [69].
Injection of capsaicin into the pancreatic duct of rats has been
shown to induce expression of the protooncogene c-fos in the
dorsal horn of spinal neurons which is an indication of
nociceptive sensory neuron activation (Fig. 1). The specificity
of this finding for capsaicin indicates the involvement of
TRPV1 [70].
In a model of experimental pancreatitis induced by injection
of L-arginine it was shown that mechanical hyperalgesia was
associated with increased expression of substance P and CGRP
mRNA in the dorsal root ganglia indicating that pancreatitis
produced sensory signals mediated by inflammatory transmit-
ters of primary sensory neurons [56]. In a comprehensive study
in rats it was shown that TRPV1, substance P, and CGRP are
expressed in the same nerve fibers of the pancreas and injection
of capsaicin resulted in NK1 receptor endocytosis in spinal
dorsal horn neurons indicative of substance P release [57].
Moreover, in a separate study of L-arginine-induced necrotizing
pancreatitis, an increase in c-fos expression in dorsal horn
neurons receiving innervation from the pancreas was observed
providing additional evidence for activation of nociceptive
pathways in pancreatitis. This coincided with an increase in
spontaneous abdominal contractions, a sign of referred
pancreatic pain. Both spinal c-fos expression and abdominal
contractions were inhibited by the TRPV1 antagonist capsaze-
pine. Additionally, c-fos expression was reduced by intrathecal
but not systemic administration of substance P and CGRP
antagonists. These findings indicate that acute necrotizing
pancreatitis activates TRPV1 on primary sensory neurons
causing the release of substance P and CGRP in the dorsal
horn to produce a nociceptive response. In contrast to other
studies which induced mild to moderately severe pancreatitis
with caerulein or pancreatico-bile duct obstruction [53,58], this
study used L-arginine to produce severe necrotizing pancreatitis
[57]. L-arginine is directly toxic to acinar cells and is known to
cause oxygen free radical formation. These differences inpancreatic injury may explain why this study did not demons-
trate a protective effect of capsazepine on pancreatitis severity.
PAR-2 is expressed on primary sensory neurons and is
activated by trypsin to expose its tethered ligand. Using a
synthetic peptide with the same amino acid sequence as the
PAR-2 ligand, it was shown that injection of the ligand into the
pancreas activated nociceptive neurons and sensitized them to
capsaicin, indicating sensitization of TRPV1 [70]. It seems
logical to propose that activated trypsin, which generates a
natural PAR-2 agonist, may also be capable of producing a
nociceptive signal during the course of pancreatitis [71]. PAR-2
is expressed by virtually all nociceptive neurons in thoracic
dorsal root ganglia that provide nerves to the pancreas and is co-
expressed with TRPV1 [71]. Moreover, intraductal trypsin
increased c-fos expression, indicating activation of spinal dorsal
horn neurons, and induced a behavioral pain response. These
effects could be ameliorated by pre-infusion of the pancreatic
duct with PAR-2 activating peptide that desensitized the
response to trypsin. These findings indicate that PAR-2
activation may also stimulate primary sensory neurons and
induce pancreatic pain.
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tion in pancreatitis have used systemic pharmacological
interventions or gene deletion methods that affect primary
afferent neurons throughout the body. One recent approach
examined the effect of interrupting pancreatic sensory nerves at
a local level to determine if a more confined strategy may be
reasonable for assessing possible therapeutic interventions [72].
Primary sensory nerves of the pancreas course through the
celiac ganglion. It was hypothesized that disruption of the celiac
ganglion by surgical excision or inhibition of C and Aδ fibers
through blockade of TRPV1 would reduce the severity of
pancreatitis. In a rat model of caerulein-induced pancreatitis, the
celiac ganglion was either surgically removed or the TRPV1
agonist resiniferatoxin was applied to the surface of the
ganglion. In high concentrations, resiniferatoxin selectively
destroys C and Aδ fibers. Animals treated with resiniferatoxin
did not demonstrate evidence of systemic sensory denervation,
thus confirming that the effects were local to the region on the
celiac ganglion. It was found that local application of
resiniferatoxin to the celiac ganglion or surgical excision of
the ganglion both reduced NK1 receptor endocytosis in
pancreatic acinar cells (indicating reduced substance P release)
and ameliorated pancreatitis. These findings confirm that the
neurogenic component of pancreatic inflammation is mediated
by TRPV1-bearing sensory nerves of which most, if not all,
course through the celiac ganglion. It is interesting to speculate
but remains to be determined if the celiac ganglion will provide
a potential site for selectively targeting sensory nerves for
treatment of pancreatic pain.
It is difficult to evaluate the contributions of neurogenic
inflammation to the pathogenesis of human pancreatitis
although several histopathological studies provide interesting
insights. In human chronic pancreatitis, increases in neural
tissue, enlargement of intrapancreatic nerves, and perineural
inflammation have been found [73]. Consistent with this
increase in neural tissue, substance P content was found to be
elevated in pancreatic nerves from chronic pancreatitis patients
[74]. Some of these changes may result from trophic effects of
local nerve growth factor, particularly since NGF receptors are
known to exist on primary sensory nerves [75]. Precisely how
these changes in sensory nerves may be related to pancreatitis-
associated pain remains to be determined.
TRPV1 has been detected in non-neuronal tissues usually
under certain pathological conditions. TRPV1 immunostaining
has been detected in human pancreatic cancer (acinar, ductal
and nerve cells) but staining intensity was greatest in nerves of
inflamed tissue surrounding the cancer [76]. TRPV1 was also
upregulated at the mRNA and protein levels in human
pancreatic cancer and in human chronic pancreatitis when
compared to normal control pancreas. Interestingly, elevated
TRPV1 expression was associated with pancreatic pain in
pancreatic cancer patients. Treatment of pancreatic cancer cells
in vitro with resiniferatoxin inhibited cell growth, produced
oxidative stress, and induced apoptosis possibly through
inhibition of mitochondrial respiration. These findings suggest
that TRPV1 expression may be upregulated in pancreatic cancer
and possibly chronic pancreatitis and may be involved inpancreatic pain. It remains to be determined if cytotoxic
therapies directed at TRPV1 are reasonable for treatment of
pancreatic cancer.
7. Other TRP channels
Although TRPV1 has been studied most extensively, other
TRP channels have been located in the pancreas. TRPV5 and
TRPV6 have been studied extensively in other epithelial tissues
where they have distinctive roles in regulating calcium home-
ostasis and may have similar roles in pancreas [77,78]. TRP-
melastatin 5 (TRPM5), although less well characterized, is also
present in pancreas [79]. A detailed study localized the mRNAs
of three TRPC channels in the pancreas [80]. TRPC3, TRPC5
and TRPC6 were all found in acinar cells of the pancreas and
only TRPC3 was found in pancreatic ducts. None of the TRPC
channels were found in pancreatic endothelium. Localization of
TRP channels in the pancreas is an important step in defining
the function of these channels in pancreatic physiology;
however, any potential role in pancreatitis is as yet unclear. It
is possible that TRP channels located on pancreatic acinar cells
could participate in pancreatic injury or secretion but this action
would be distinct from the better defined role of TRPV1 in
neurogenic inflammation. In contrast, however, TRPV4 resides
on primary afferent neurons and senses even mild changes in
osmolarity [81,82]. It was recently shown that PAR-2 sensitizes
TRPV4 to cause mechanical hyperalgesia through phospholi-
pase Cβ and protein kinase A, C, and D pathways [83]. It is
unknown whether TRPV4 contributes to the neurogenic
component of pancreatitis but it is possible that it plays a role
in pancreatic pain.
8. Conclusions
A number of other experimental approaches have helped
elucidate the role of sensory neurons in the pancreas.
Identification of sensory neurons through the use of novel
immunological stains, sensitive histological approaches, and
electrophysiological techniques have illustrated the anatomical
and physiological properties of primary sensory neural path-
ways. The ability to identify the specific neuropeptides within
primary sensory neurons through co-localization studies,
understanding the regulation of their release, and defining
their proinflammatory properties have been instrumental in
defining the role of neurogenic inflammation.
Characterization of TRPV1 channels on primary sensory
neurons has been a major advance in the study of neurogenic
inflammation and has greatly expanded our understanding of
the activation of sensory pathways. The consequences of
sensory nerve stimulation has been brought to light through the
use of TRPV1 agonists and antagonists and new mouse models
with genetic modifications of TRPV1, neuropeptides and their
receptors including NK1 receptors. Additional techniques such
as quantification of NK1 receptor endocytosis have opened new
doors for understanding not only receptor biology but basic
mechanisms of neurogenic inflammation. As these findings
have been applied to the pancreas we have gained new insights
876 R.A. Liddle / Biochimica et Biophysica Acta 1772 (2007) 869–878into the pathogenesis of pancreatitis. There is a growing body of
evidence that activation of primary sensory nerves is an early
event in the development of acute pancreatitis and causes the
release of proinflammatory neuropeptides such as substance P
and CGRP both in the spinal cord to signal pain and in the
periphery to induce local inflammation. Stimulation of primary
sensory neurons occurs in large part through activation of
TRPV1 although other receptors are also involved. The specific
endogenous agonists that are released during the course of
pancreatic injury have not yet been definitively identified,
although a number of reasonable candidates exist.
Although tremendous progress has been made in under-
standing the role of TRP channels in pancreatitis, a number of
other important questions remain. Specifically, what are the
endogenous activators of TRPV1, what is their source, and how
are they generated? What is the relationship between TRP
channel activation and pancreatic enzyme activation in the
pancreas? Is neurogenic inflammation or TRPV1 activation a
necessary requirement for the generation of pancreatitis? Does
neurogenic inflammation play a role in chronic pancreatitis?
The answer to each of these questions will be important in order
to fully understand the role of TRP channels in pancreatitis.
Ultimately, we hope this information will lead us to new
strategies for preventing or treating human pancreatitis.
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